This heterogeneous response contrasts with the response seen with other therapeutic approaches to the tumour vasculature, for example, inhibition of VEGF signalling, where the histogram shifts to the left but the shape remains unchanged (Checkley et al, 1999, 2001). This evidence concerns the gene VEGFA and neoplasm.